Form 4: Dentsply Sirona CEO Simon Campion Reports Acquisition of Restricted Stock Units and Stock Options
SEC Form 4 Filing
Dentsply Sirona's CEO, Simon Campion, reports the acquisition of restricted stock units and stock options, according to a Form 4 filing with the SEC.
Summary
- Simon D. Campion, the President, CEO, and a member of the Board of Directors of Dentsply Sirona Inc. [XRAY], filed a Form 4 with the SEC.
- The filing reports a transaction date of March 4, 2024.
- Campion acquired 48,978 shares of common stock in the form of Restricted Stock Units (RSUs) at a price of $0.
- These RSUs vest in annual one-third increments over a three-year period, ending on March 4, 2027.
- Campion also acquired 163,800 stock options with an exercise price of $33.28.
- These stock options vest in annual one-third increments over a three-year period, also ending on March 4, 2027.
- Following the reported transactions, Campion beneficially owns 290,374.1901 shares of common stock and 163,800 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, aligning management interests with shareholders. There are no immediate negative implications.
Positives
- The acquisition of RSUs and stock options aligns the CEO's interests with those of the shareholders, incentivizing him to improve the company's performance.
- The vesting schedule of the RSUs and stock options encourages long-term commitment from the CEO.
Industry Context
This type of equity compensation is common for CEOs in publicly traded companies to align their interests with shareholder value.
Comparison to Industry Standards
- Equity compensation packages for CEOs in the dental and medical device industry typically include a mix of stock options and restricted stock units.
- Vesting schedules of three years are standard practice to ensure long-term commitment.
- Comparing Campion's equity holdings and compensation structure to peers at companies like Align Technology (ALGN) or Straumann Holding AG (STMN) would provide a more detailed benchmark.
Stakeholder Impact
- Shareholders may view the equity grants positively as they align management's interests with the company's long-term success.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/04/2024 | Date of transaction: Acquisition of RSUs and stock options. |
| 03/04/2027 | Final vesting date for both RSUs and stock options. |
| 03/06/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.